Clinical Trials Directory

Trials / Sponsors / Alkahest, Inc.

Alkahest, Inc.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Re
Diabetic Retinopathy
Phase 22021-08-17
CompletedStudy to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hem
End-Stage Renal Disease
N/A2021-03-11
CompletedA Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairm
Cognitive Impairment, End Stage Renal Disease
N/A2020-04-28
TerminatedA Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid
Pemphigoid, Bullous
Phase 22020-01-30
CompletedA Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD
Neovascular Age-related Macular Degeneration
Phase 22020-01-28
CompletedStudy Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Tr
Parkinson Disease
Phase 22020-01-16
CompletedA Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty
Postoperative Recovery
Phase 22019-07-12
CompletedA Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
Severe Alzheimer Disease
Phase 22019-01-15
CompletedA Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairmen
Parkinson Disease
Phase 22018-11-12
CompletedEvaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Deg
Wet Age-related Macular Degeneration
Phase 22018-04-20
CompletedA Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Dis
Alzheimer Disease, Mild to Moderate Alzheimer Disease
Phase 22018-04-16
CompletedEvaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degenerati
Wet Age-related Macular Degeneration
Phase 22018-04-04